Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00745849 · ClinicalTrials.gov registry record · NA
Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial
A NA study of Vasomotor Rhinitis, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT00745849 is a NA study of Vasomotor Rhinitis that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00745849, a NA study of Vasomotor Rhinitis, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to see if high dose esomeprazole (40mg bid) was effective in treating non-allergic rhinitis
Conditions Studied
Interventions
- DRUG placebo
- DRUG esomeprazole
Study Locations (1)
Texas
- Clinical Trials Office, Aston Building, UT Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00745849
The ClinicalTrials.gov registry entry for NCT00745849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vasomotor Rhinitis appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00745849 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00745849 about?
NCT00745849 is a clinical study titled "Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial". The purpose of this study was to see if high dose esomeprazole (40mg bid) was effective in treating non-allergic rhinitis
What is the current status of trial NCT00745849?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2005-06. Estimated completion is 2008-03.
What conditions does trial NCT00745849 study?
This clinical trial studies the following conditions: Vasomotor Rhinitis.
What interventions are being tested in trial NCT00745849?
The interventions under investigation include: placebo (DRUG), esomeprazole (DRUG).
Who is sponsoring clinical trial NCT00745849?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00745849 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.